Gene · 822
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FYB1-targeted modulation of CAPG promotes AML progression. | Mol Cell Biochem | 2025 | 38700746 | PubTator, text mining | PubMed |
| Genome scale CRISPR screens identify actin capping proteins as key modulators of therapeutic responses to radiation and immunotherapy. | bioRxiv | 2025 | 38293095 | PubTator, text mining | PubMed |
| Modeling Viral Capsid Assembly: A Review of Computational Strategies and Applications. | Cells | 2024 | 39768179 | PubTator, text mining | PubMed |
| A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma. | Hereditas | 2024 | 39707577 | PubTator, text mining | PubMed |
| The nucleocapsid architecture and structural atlas of the prototype baculovirus define the hallmarks of a new viral realm. | Sci Adv | 2024 | 39693434 | PubTator, text mining | PubMed |
| Cytoskeleton Remodeling-Related Proteins Represent a Specific Salivary Signature in PSC Patients. | Molecules | 2024 | 39683940 | PubTator, text mining | PubMed |
| Identification of CAPG as a potential prognostic biomarker associated with immune cell infiltration and ferroptosis in uterine corpus endometrial carcinoma. | Front Endocrinol (Lausanne) | 2024 | 39600941 | PubTator, text mining | PubMed |
| A modular platform for bioluminescent RNA tracking. | Nat Commun | 2024 | 39557883 | PubTator, text mining | PubMed |
| Repeated FRAP of the actin-binding protein CapG in the cell nucleus-a functional assay for EGF signaling in the single live breast cancer cell. | Sci Rep | 2024 | 39369027 | PubTator, text mining | PubMed |
| A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma. | Sci Rep | 2024 | 39261532 | PubTator, text mining | PubMed |
| Distributed Collaboration for Data, Analysis Pipelines, and Results in Single-Cell Omics. | bioRxiv | 2024 | 39131282 | PubTator, text mining | PubMed |
| A novel mitochondrial function-associated programmed cell death-related prognostic signature for predicting the prognosis of early breast cancer. | Front Genet | 2024 | 39015775 | PubTator, text mining | PubMed |
| DNA break induces rapid transcription repression mediated by proteasome-dependent RNAPII removal. | Cell Rep | 2024 | 38954517 | PubTator, text mining | PubMed |
| Targeted serum proteome profiling reveals nicotinamide adenine dinucleotide phosphate (NADPH)-related biomarkers to discriminate linear IgA bullous disorder from dermatitis herpetiformis. | Clin Immunol | 2024 | 38908771 | PubTator, text mining | PubMed |
| A novel single-cell model reveals ferroptosis-associated biomarkers for individualized therapy and prognostic prediction in hepatocellular carcinoma. | BMC Biol | 2024 | 38853238 | PubTator, text mining | PubMed |
| Targeting the MCP-GPX4/HMGB1 Axis for Effectively Triggering Immunogenic Ferroptosis in Pancreatic Ductal Adenocarcinoma. | Adv Sci (Weinh) | 2024 | 38593415 | PubTator, text mining | PubMed |
| Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Suppresses macrophage capping protein beyond STING activation. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38565383 | PubTator, text mining | PubMed |
| In situ imaging of mRNA transcripts based on split-aptamer and split protein in living cells. | RSC Adv | 2024 | 38544938 | PubTator, text mining | PubMed |
| Correspondence on Editorial regarding "Identification of signature gene set as highly accurate determination of MASLD progression". | Clin Mol Hepatol | 2024 | 38390704 | PubTator, text mining | PubMed |
| The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective. | Clin Mol Hepatol | 2024 | 38311818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/822/papers?page=5